Matches in Wikidata for { <http://www.wikidata.org/entity/Q63571216> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- Q63571216 description "clinical trial" @default.
- Q63571216 description "ensayu clínicu" @default.
- Q63571216 description "klinisch onderzoek" @default.
- Q63571216 description "клінічне випробування" @default.
- Q63571216 name "A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma" @default.
- Q63571216 type Item @default.
- Q63571216 label "A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma" @default.
- Q63571216 prefLabel "A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma" @default.
- Q63571216 P1050 Q63571216-3F896E97-D7A9-4EEB-9CC5-046FC33043B9 @default.
- Q63571216 P1132 Q63571216-F3B7E629-8A79-4C24-A3F9-10BD4616690C @default.
- Q63571216 P1476 Q63571216-FF3FDE9C-711D-46C9-BE8C-87ECE80D925A @default.
- Q63571216 P17 Q63571216-0809A3B8-CA6D-4001-853F-57490DF61918 @default.
- Q63571216 P17 Q63571216-1D7F1779-ED38-4F8A-B727-B26B41B951BD @default.
- Q63571216 P17 Q63571216-261411BC-7962-43C9-822E-79B7E0CD79F8 @default.
- Q63571216 P17 Q63571216-3E8CC9CA-232E-4667-8111-96CBA3BB4AE2 @default.
- Q63571216 P17 Q63571216-8391303F-1769-44AB-B0CF-6067ED4FD05B @default.
- Q63571216 P17 Q63571216-8EBC3640-B0FC-436E-9154-2D618EBAAFBE @default.
- Q63571216 P17 Q63571216-A7E8C872-808A-42E1-8840-3FB1E36BE8A7 @default.
- Q63571216 P17 Q63571216-A822C9EE-AD1D-465B-8BFF-539A0E72AE4C @default.
- Q63571216 P17 Q63571216-A894321A-9C73-408E-9F56-8799D650FB66 @default.
- Q63571216 P17 Q63571216-AFFF861E-F288-45CA-B299-E50F109D5FAA @default.
- Q63571216 P17 Q63571216-CBF41646-DED2-4187-8EE1-A10FDCE46D42 @default.
- Q63571216 P17 Q63571216-E410519A-BAAD-4D70-A199-2BEA436BB44D @default.
- Q63571216 P2899 Q63571216-52A21466-1F49-4905-BF2A-939C8BB3C0B2 @default.
- Q63571216 P3098 Q63571216-1EC0A54D-545C-4BAD-A5E1-F18668538E91 @default.
- Q63571216 P31 Q63571216-4D4B97B5-649C-40EC-AC45-38CF74B576C8 @default.
- Q63571216 P4844 Q63571216-9D98E14F-154E-4857-9538-29B8E37FE68C @default.
- Q63571216 P580 Q63571216-07AE6B32-4967-4A09-9395-5382A82DED70 @default.
- Q63571216 P582 Q63571216-0E557B46-751C-4FF2-BA7A-32D1D3D88336 @default.
- Q63571216 P6099 Q63571216-21180DAD-3500-4A0C-A5B2-E200E6D45ACC @default.
- Q63571216 P6153 Q63571216-0380893C-DF9E-43A8-AD62-5E7329839171 @default.
- Q63571216 P6153 Q63571216-03879B4F-0345-4094-9F9E-75449F9F1B61 @default.
- Q63571216 P6153 Q63571216-0E929B3C-477B-4F12-95CC-FC643399DB2E @default.
- Q63571216 P6153 Q63571216-1F3AE0E7-1B99-454D-944B-9A64C5DE114E @default.
- Q63571216 P6153 Q63571216-1FF60315-3639-489B-9A1E-24E05870A8B5 @default.
- Q63571216 P6153 Q63571216-3FC1CBFA-FB92-4191-89AA-27316CCFBE4C @default.
- Q63571216 P6153 Q63571216-5B293C27-9FC8-4865-92B0-35A50FB32938 @default.
- Q63571216 P6153 Q63571216-7A63355D-6789-4EDA-9CA0-C1AB737333AC @default.
- Q63571216 P6153 Q63571216-820555F9-68C1-41E7-92AE-B0A0E1788E23 @default.
- Q63571216 P6153 Q63571216-865B665C-BA21-4649-9D14-FB783416DB8A @default.
- Q63571216 P6153 Q63571216-9A485FAE-879A-4F7A-BCFC-C1896B4511F7 @default.
- Q63571216 P6153 Q63571216-D073F23B-D67D-4227-BEF8-878CB64DFD5B @default.
- Q63571216 P6153 Q63571216-DD3DBD7B-AB32-4965-B53E-E132252B57A5 @default.
- Q63571216 P6153 Q63571216-EF26CF69-673F-43FC-A62E-BD55CF35E038 @default.
- Q63571216 P6153 Q63571216-F2C1F2C6-9EBA-4DA6-BA70-39BE0F6699C0 @default.
- Q63571216 P6153 Q63571216-F93CD8C6-D418-45FB-8A56-5797B2DC04F8 @default.
- Q63571216 P6153 Q63571216-FDCFF18F-F5C8-499B-A7B3-8E69281778BE @default.
- Q63571216 P8363 Q63571216-9130025A-48E4-4514-8E46-62BBC0158FF9 @default.
- Q63571216 P859 Q63571216-E787BEF7-7BC4-4059-9B05-F1BB583E3DD2 @default.
- Q63571216 P1050 Q180614 @default.
- Q63571216 P1132 "+481" @default.
- Q63571216 P1476 "Phase IIIb/IV, Randomized, Double Blinded, Study of Nivolumab 3 mg/kg in Combination With Ipilimumab 1 mg/kg vs Nivolumab 1 mg/kg in Combination With Ipilimumab 3 mg/kg in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma" @default.
- Q63571216 P17 Q142 @default.
- Q63571216 P17 Q145 @default.
- Q63571216 P17 Q16 @default.
- Q63571216 P17 Q183 @default.
- Q63571216 P17 Q29 @default.
- Q63571216 P17 Q30 @default.
- Q63571216 P17 Q35 @default.
- Q63571216 P17 Q36 @default.
- Q63571216 P17 Q38 @default.
- Q63571216 P17 Q408 @default.
- Q63571216 P17 Q55 @default.
- Q63571216 P17 Q801 @default.
- Q63571216 P2899 "+18" @default.
- Q63571216 P3098 "NCT02714218" @default.
- Q63571216 P31 Q30612 @default.
- Q63571216 P4844 Q7041828 @default.
- Q63571216 P580 "2016-03-24T00:00:00Z" @default.
- Q63571216 P582 "2017-04-20T00:00:00Z" @default.
- Q63571216 P6099 Q42824827 @default.
- Q63571216 P6153 Q1294736 @default.
- Q63571216 P6153 Q16508267 @default.
- Q63571216 P6153 Q192334 @default.
- Q63571216 P6153 Q213439 @default.
- Q63571216 P6153 Q219563 @default.
- Q63571216 P6153 Q266227 @default.
- Q63571216 P6153 Q2945675 @default.
- Q63571216 P6153 Q2945741 @default.
- Q63571216 P6153 Q30286943 @default.
- Q63571216 P6153 Q3151727 @default.
- Q63571216 P6153 Q500606 @default.
- Q63571216 P6153 Q5188247 @default.
- Q63571216 P6153 Q5225736 @default.
- Q63571216 P6153 Q5637237 @default.
- Q63571216 P6153 Q6518847 @default.
- Q63571216 P6153 Q7972509 @default.
- Q63571216 P6153 Q850730 @default.
- Q63571216 P8363 Q78089383 @default.
- Q63571216 P859 Q266423 @default.